Due to the involvement of TNF-α in the pathogenesis of autoimmune diseases, TNF-α inhibitors have been successfully developed and applied in the clinical treatment of autoimmune diseases such as Crohn’s disease (CD) and RA [27,28]. The gene discussed is TNF; the disease is rheumatoid arthritis.